Your browser is no longer supported. Please, upgrade your browser.
JNJ Johnson & Johnson weekly Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E23.24 EPS (ttm)6.25 Insider Own0.08% Shs Outstand2.63B Perf Week-1.93%
Market Cap381.97B Forward P/E16.14 EPS next Y9.00 Insider Trans-2.02% Shs Float2.63B Perf Month0.39%
Income16.69B PEG5.37 EPS next Q1.83 Inst Own70.20% Short Float0.44% Perf Quarter-1.32%
Sales80.86B P/S4.72 EPS this Y0.50% Inst Trans-0.07% Short Ratio1.93 Perf Half Y-5.87%
Book/sh24.49 P/B5.93 EPS next Y12.42% ROA9.50% Target Price166.18 Perf Year13.91%
Cash/sh11.70 P/C12.41 EPS next 5Y4.33% ROE24.50% 52W Range109.16 - 157.00 Perf YTD-0.43%
Dividend4.04 P/FCF52.47 EPS past 5Y-0.20% ROI17.30% 52W High-7.49% Beta0.66
Dividend %2.78% Quick Ratio1.20 Sales past 5Y2.00% Gross Margin65.80% 52W Low33.05% ATR2.53
Employees132200 Current Ratio1.50 Sales Q/Q1.70% Oper. Margin20.20% RSI (14)43.50 Volatility1.78% 1.56%
OptionableYes Debt/Eq0.59 EPS Q/Q102.70% Profit Margin18.80% Rel Volume0.69 Prev Close145.08
ShortableYes LT Debt/Eq0.51 EarningsOct 13 BMO Payout66.90% Avg Volume5.94M Price145.24
Recom1.90 SMA20-1.40% SMA50-2.23% SMA200-0.11% Volume4,154,372 Change0.11%
Apr-28-20Downgrade UBS Buy → Neutral $163 → $160
Apr-22-20Upgrade BofA/Merrill Neutral → Buy $150 → $175
Mar-05-20Initiated Citigroup Buy $163
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-25-20 02:33PM  
11:32AM  
06:25AM  
Oct-24-20 08:00AM  
06:45AM  
06:17AM  
Oct-23-20 11:09PM  
04:57PM  
04:52PM  
04:52PM  
04:33PM  
04:25PM  
04:17PM  
03:54PM  
03:30PM  
11:33AM  
10:05AM  
09:44AM  
Oct-22-20 04:51PM  
04:28PM  
04:25PM  
03:34PM  
02:16PM  
01:59PM  
01:43PM  
12:48PM  
12:44PM  
12:04PM  
10:37AM  
10:19AM  
10:15AM  
09:00AM  
Oct-21-20 04:34PM  
04:25PM  
12:14PM  
12:05PM  
Oct-20-20 04:26PM  
03:49PM  
02:11PM  
11:28AM  
10:12AM  
06:30AM  
Oct-19-20 04:51PM  
04:32PM  
04:25PM  
02:40PM  
12:05PM  
10:01AM  
Oct-17-20 08:09AM  
07:40AM  
Oct-16-20 10:12PM  
06:49PM  
06:07PM  
04:57PM  
04:25PM  
03:38PM  
03:36PM  
03:24PM  
01:53PM  
01:53PM  
09:57AM  
07:58AM  
Oct-15-20 08:05PM  
04:31PM  
04:25PM  
04:08PM  
03:19PM  
11:59AM  
11:31AM  
10:46AM  
09:41AM  
09:00AM  
07:33AM  
Oct-14-20 04:59PM  
04:44PM  
04:29PM  
04:25PM  
04:22PM  
03:42PM  
11:45AM  
11:14AM  
09:22AM  
08:38AM  
08:35AM  
08:23AM  
07:57AM  
07:26AM  
06:55AM  
06:38AM  
01:42AM  
Oct-13-20 10:49PM  
10:21PM  
08:55PM  
07:33PM  
07:01PM  
06:25PM  
05:32PM  
04:49PM  
04:25PM  
04:24PM  
Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Option Exercise63.7516,1151,027,32374,535Sep 04 02:58 PM
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Sale153.5216,1152,473,93858,420Sep 04 02:58 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesJul 28Sale147.4729,0004,276,63021,682Jul 28 06:43 PM
JOHNSON & JOHNSON10% OwnerJun 30Buy17.00725,00012,325,0003,670,516Jul 02 04:58 PM
PEREZ WILLIAM DDirectorMar 13Buy127.6950063,84316,030Mar 17 04:24 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 21Option Exercise90.4419,2241,738,61975,039Feb 25 04:23 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 21Sale147.9639,2245,803,58335,815Feb 25 04:23 PM
Ullmann Michael HExec VP, General CounselFeb 13Option Exercise0.0020,3260152,697Feb 18 05:03 PM
Wolk Joseph JExec VP, CFOFeb 13Option Exercise0.007,080021,387Feb 18 05:03 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 13Option Exercise0.0015,809065,532Feb 18 05:03 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 13Option Exercise0.0022,2310110,559Feb 18 05:03 PM
Decker Robert JController, CAOFeb 13Option Exercise0.001,499013,946Feb 18 05:03 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 13Option Exercise0.00105,6680220,373Feb 18 05:03 PM
Gorsky AlexChairman, CEOFeb 13Option Exercise0.00107,0160496,472Feb 18 05:03 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 13Option Exercise0.0013,747056,496Feb 18 05:03 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 13Option Exercise0.003,692057,259Feb 18 05:03 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 13Option Exercise0.0011,836061,219Feb 18 05:03 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 13Option Exercise0.0039,3810270,900Feb 18 05:03 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 13Option Exercise0.0016,0840115,813Feb 18 05:03 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 03Option Exercise0.0048,3120123,450Feb 04 07:31 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 03Option Exercise0.0038,650058,154Feb 04 07:31 PM
Sneed Michael EEVP, Global Corp Aff & COOJan 30Option Exercise62.6258,1283,639,975107,511Feb 03 06:28 PM
Sneed Michael EEVP, Global Corp Aff & COOJan 30Sale149.3958,1288,683,56849,383Feb 03 06:28 PM
Joly HubertDirectorDec 13Buy141.285,000706,3995,000Dec 16 04:40 PM
Wengel Kathryn EEVP, Chief GSC OfficerDec 12Option Exercise62.622,017126,30551,736Dec 16 05:40 PM
Wengel Kathryn EEVP, Chief GSC OfficerDec 12Sale141.072,017284,53849,719Dec 16 05:40 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.